VERVE THERAPEUTICS INC's ticker is VERV and the CUSIP is 92539P101. A total of 122 filers reported holding VERVE THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 0.13 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $27,917 | -29.1% | 2,105,298 | +0.2% | 0.02% | -25.9% |
| Q2 2023 | $39,401 | +36.2% | 2,101,361 | +4.7% | 0.03% | +28.6% |
| Q1 2023 | $28,929 | -16.9% | 2,006,127 | +11.5% | 0.02% | -22.2% |
| Q4 2022 | $34,824 | -99.9% | 1,799,650 | +43.4% | 0.03% | -20.6% |
| Q3 2022 | $43,103,000 | – | 1,254,816 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Green Alpha Advisors, LLC | 22,366 | $311,782 | 0.22% |